Cracking The Asia Pacific Ophthalmology Amniotic Membrane Market Code

Cracking The Asia Pacific Ophthalmology Amniotic Membrane Market Code

Asia Pacific ophthalmology amniotic membrane market valued USD 106.7 million in 2022 and is estimated to grow at a CAGR of 6.7%

2021-08-26

Asia Pacific ophthalmology amniotic membrane market valued USD 106.7 million in 2022 and is estimated to grow at a CAGR of 6.7% to reach USD YY million by 2029

Increasing incidences of eye disorders owing to changing lifestyles and the aging population are the major factor driving the demand for amniotic membrane treatment in the Asia Pacific region

Also, there has been significant growth in the early diagnosis and treatment of eye-related disorders in countries such as India, China, and Indonesia. These countries have a large population with an unmet need for vision treatment. The awareness of the benefits of natural, regenerative replenishment of damaged eyes has been growing resulting in demand for ophthalmology amniotic membranes

The prevalence of eye diseases such as glaucoma and AMD is high in these countries. Amniotic membrane is used in trabeculectomy for treating primary open-angle glaucoma

China and India have the highest prevalence of glaucoma in the world, with several cases recorded as nearly 22 million and 16 million respectively in 2020. However, the rate of diagnosis and treatment in these countries is significantly lower than in the U.S. and Europe regions

Moreover, a large number of glaucoma surgeries are resulting in the development of Bullous keratopathy, thereby propelling the scope for use of amniotic membrane treatment. 

Besides cornea damage by an intraocular lens, glaucoma surgery is considered as the most common reason for the development of bullous keratopathy. Trabeculectomy is dominating over 85% of treatment for primary open-angle glaucoma (POAG) in China and is one of the possible causes of several cornea-related disorders

Pterygium is another key ocular disorder spurring the demand for amniotic membranes in the region. It is a degenerative disorder with a triangular fleshy fibrovascular proliferation onto the cornea

It is highly prevalent in the geography lying between 30 degrees north and 30 degrees south of the equator. In 2017, the prevalence rate of Pterygium is recorded as 15% among Chinese, 30% among Japanese, and 7% among Indians

The amniotic membrane is used as a vital part in the surgical treatment of Pterygium. AM graft is placed in the region of scleral exposure to reduce the chances of recurrence. The amniotic graft is preferred over conjunctival autograft and other alternatives as AM does not require an additional surgery site for its placement

The development in healthcare facilities associated with ophthalmology and the use of regenerative procedures in ocular treatment is another macro factor driving the market growth in the region. Countries such as Singapore, Thailand, and South Korea have been witnessing a growth in contract research outsourcing. These countries are fuelled by the presence of highly-sophisticated research facilities and storage infrastructures such as cell banks and placenta bank

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

Found it interesting?

Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866

We have 5000+ marketing reports and serve across 130+ countries

Tags:

#asiapasificopthalmologyamnioticmembranemarket,